• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Sloning BioTechnology

edit

Sloning BioTechnology has developed a unique and patented technology platform to build DNA molecules with exceptional features regarding sequence limitations, reliability and production cost on an industrial scale robotic system – the Slonomics™ technology platform.

Recent Milestones

edit

• 
  Sloning BioTechnology was acquired by MorphoSys. (10/8/10)
  Posted 10/19/10 at 1:08am via dowjones.com
• 
  Sloning BioTechnology received $6.78M (€4.7M) in Series E funding. (11/1/07)
  Posted 3/16/10 at 12:04am via sloning.com
• 
  Sloning BioTechnology received $3.91M (€3.1M) in Series C funding. (5/18/05)
  Posted 8/31/10 at 3:12am via sloning.com

Videos

Screenshots

edit

Above: Sloning BioTechnology
Uploaded: 3/16/10

Sources

1. MorphoSys Buys Sloning For $26.4M, Gains Synthetic Bio Technology (fis.dowjones.com) [edit]
2. Sloning BioTechnology closes new round of financing (sloning.com) [edit]
3. Sloning BioTechnology GmbH Raised € 4.7m in a First Closing of a Series E Equity Financing Round (sloning.com) [edit]